Skip to main content.

Pfizer

Picture of Kellie  Schmitt
As U.S. vaccination rates plummet, an expert panel discusses whether new incentives such as prizes and lotteries could help the country meet its vaccination goal.
Picture of Susan  Abram

The makers of popular drugs like Advair, Cymbalta, Viagra and Zoloft have physicians, psychiatrists, and medical school faculty members across California on their payrolls. Does this influence prescribing patterns?

Picture of William Heisel

Bioethicist Leigh Turner, recently under fire from a stem cell company he criticized for ethical problems, talks about his research on medical tourism.

Picture of Barbara Feder Ostrov

A moving examination of how doctors choose to die, a big-money Prempro lawsuit, and FDA scrutiny of the HCG diet, plus more from our Daily Briefing.

Picture of William Heisel

I wrote a piece recently for Health News Review about conflicts of interest. The original post is below, followed by more great examples of writers describing unexpected conflicts in detail.

Picture of Andrew Holtz

Normally I would salivate over a workshop titled "Let Me Be Clear: Science Journalism in the Age of the Genome and Twitter." But then my building excitement and anticipation was doused by a real buzz kill in the middle of the sponsor logos.

Picture of Ricki Lewis

After 60+ years of smoking, my mother-in-law’s lungs were surely a toxic wasteland, yet nothing would make her quit. Journalist Ricki Lewis examines the risks and benefits of Chantix and highlights a new way to get smokers to quit: texting.

Picture of William Heisel

William Heisel interviews health writer Liz Scherer about the latest coverage of the Women's Health Initiative study on hormone replacement therapy and her tips for covering women's health.

Picture of William Heisel

Health journalists and patient advocates should be on high alert for the changes that are sure to come with the announcement last week that the FDA has approved the Lap-Band device for nearly every person with a few pounds to lose.

Picture of Barbara Feder Ostrov

Here’s what we’re reading today:

Journalists’ Pfriend? Gary Schwitzer and Andrew Holtz weigh in on Pfizer’s sponsorship of a National Press Foundation education program about Alzheimer's, a disease for which Pfizer makes medications.

Medical Loss Ratios: If you’re wondering what these are, check out Merrill Goozner’s analysis of some recent proposed regulations on this key element of health reform.

Pages

Announcements

The nation's top infectious disease specialist will join us for a conversation with national health reporter Dan Diamond of The Washington Post. We’ll talk about the evolving threat posed by monkeypox, the current state of the COVID pandemic, and broader lessons on how we respond to emerging diseases. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth